| Dr Reeta Rohatgi, MD | |
|
402 S Silver Springs Rd, Cape Girardeau, MO 63703-7536 | |
| (573) 334-1100 | |
| (573) 651-4345 |
| Full Name | Dr Reeta Rohatgi |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 402 S Silver Springs Rd, Cape Girardeau, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144331687 | NPI | - | NPPES |
| 202238507 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | R4F88 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Reeta Rohatgi, MD 402 S Silver Springs Rd, Cape Girardeau, MO 63703-7536 Ph: (573) 334-1100 | Dr Reeta Rohatgi, MD 402 S Silver Springs Rd, Cape Girardeau, MO 63703-7536 Ph: (573) 334-1100 |
News Archive
Each year, heart attacks kill almost 10 million people in the world, and more than 6 million die from stroke. A heart attack is caused by a clot that blocks the artery blood flow. Unirrigated tissues are deprived from the oxygen that is carried by the blood. Under these conditions, the affected tissues undergo a rapid necrosis.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.
MDLGI provides hospitals; gastroenterologists; surgeons; capsule endoscopy programs; GI clinics; as well as GERD, esophageal and reflux centers around the globe a unique ability allowing consultation with the world's leading GI experts for detailed analyses of esophageal function testing...
Teva Pharmaceutical Industries Ltd. announced today that Teva-KOWA Pharma Co., Ltd., the Company's joint venture in Japan with KOWA Company, Ltd., has signed a definitive agreement to acquire a majority of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.
A novel technology named BiOWiSH is helping communities in emerging markets improve their wastewater treatment operations without building or expanding infrastructure, according to the findings of a new case study.
› Verified 4 days ago
Bradley D. Robison, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 106 Farrar Dr, Suite 109, Cape Girardeau, MO 63701 Phone: 573-334-7055 Fax: 573-334-7961 | |
Dr. Aleksey Aleksandrovich Androsov, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5893 Fax: 573-331-5073 | |
Robert E Gardner, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3250 Gordonville Rd Ste 450, Cape Girardeau, MO 63703 Phone: 573-651-3188 Fax: 573-651-3048 | |
Dr. Abdul B Chaudhari, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1723 Broadway, Suite 210, Cape Girardeau, MO 63701 Phone: 573-331-7840 Fax: 573-331-7849 | |
Steven D Mellies, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3250 Gordonville Rd Ste 206, Cape Girardeau, MO 63703 Phone: 573-651-3188 Fax: 573-651-3048 | |
Richard Daniel Ronca, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 211 Saint Francis Dr, Cape Girardeau, MO 63703 Phone: 573-331-5893 Fax: 573-331-3974 |